Literature DB >> 23180474

Differences in outcomes of oesophageal and gastric cancer surgery across Europe.

J L Dikken1, J W van Sandick, W H Allum, J Johansson, L S Jensen, H Putter, V H Coupland, M W J M Wouters, V E P Lemmens, C J H van de Velde, L G M van der Geest, H J Larsson, A Cats, M Verheij.   

Abstract

BACKGROUND: In several European countries, centralization of oesophagogastric cancer surgery has been realized and clinical audits initiated. The present study was designed to evaluate differences in resection rates, outcomes and annual hospital volumes between these countries, and to analyse the relationship between hospital volume and outcomes.
METHODS: National data were obtained from cancer registries or clinical audits in the Netherlands, Sweden, Denmark and England. Differences in outcomes were analysed between countries and between hospital volume categories, adjusting for available case-mix factors.
RESULTS: Between 2004 and 2009, 10 854 oesophagectomies and 9010 gastrectomies were registered. Resection rates in England were 18·2 and 21·6 per cent for oesophageal and gastric cancer respectively, compared with 28·5-29·9 and 41·4-41·9 per cent in the Netherlands and Denmark (P < 0·001). The adjusted 30-day mortality rate after oesophagectomy was lowest in Sweden (1·9 per cent). After gastrectomy, the adjusted 30-day mortality rate was significantly higher in the Netherlands (6·9 per cent) than in Sweden (3·5 per cent; P = 0·017) and Denmark (4·3 per cent; P = 0·029). Increasing hospital volume was associated with a lower 30-day mortality rate after oesophagectomy (odds ratio 0·55 (95 per cent confidence interval 0·42 to 0·72) for at least 41 versus 1-10 procedures per year) and gastrectomy (odds ratio 0·64 (0·41 to 0·99) for at least 21 versus 1-10 procedures per year).
CONCLUSION: Hospitals performing larger numbers of oesophagogastric cancer resections had a lower 30-day mortality rate. Differences in outcomes between several European countries could not be explained by differences in hospital volumes. To understand these differences in outcomes and resection rates, with reliable case-mix adjustments, a uniform European upper gastrointestinal cancer audit with recording of standardized data is warranted.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23180474     DOI: 10.1002/bjs.8966

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  48 in total

1.  Way forward: Geriatric frailty assessment as risk predictor in gastric cancer surgery.

Authors:  Juul Jw Tegels; Jan Hmb Stoot
Journal:  World J Gastrointest Surg       Date:  2015-10-27

2.  Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.

Authors:  Silvio Däster; Savas D Soysal; Luca Koechlin; Lea Stoll; Ralph Peterli; Markus von Flüe; Christoph Ackermann
Journal:  Langenbecks Arch Surg       Date:  2016-07-19       Impact factor: 3.445

3.  Staging and surgical approaches in gastric cancer: a clinical practice guideline.

Authors:  N Coburn; R Cosby; L Klein; G Knight; R Malthaner; J Mamazza; C D Mercer; J Ringash
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

Review 4.  Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery.

Authors:  Ines Gockel; Constantin Johannes Ahlbrand; Michael Arras; Elke Maria Schreiber; Hauke Lang
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

Review 5.  Lymphadenectomy: how to do it?

Authors:  Simone Giacopuzzi; Maria Bencivenga; Chiara Cipollari; Jacopo Weindelmayer; Giovanni de Manzoni
Journal:  Transl Gastroenterol Hepatol       Date:  2017-04-07

Review 6.  Is There a Rationale for Structural Quality Assurance in Esophageal Surgery?

Authors:  Torben Glatz; Jens Höppner
Journal:  Visc Med       Date:  2017-03-24

Review 7.  Do all the European surgeons perform the same D2? The need of D2 audit in Europe.

Authors:  Maria Bencivenga; Giuseppe Verlato; Valentina Mengardo; Jacopo Weindelmayer; William H Allum
Journal:  Updates Surg       Date:  2018-06-04

Review 8.  Gastric cancer surgery: historical background and perspective in Western countries versus Japan.

Authors:  Chun-Dong Zhang; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Ann Transl Med       Date:  2019-09

9.  The value of esophagectomy surgical apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy.

Authors:  Xue-Zhong Xing; Hai-Jun Wang; Shi-Ning Qu; Chu-Lin Huang; Hao Zhang; Hao Wang; Quan-Hui Yang; Yong Gao
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

10.  [Hospital volume effects in surgical treatment of gastric cancer : Results of a prospective multicenter observational study].

Authors:  H Ptok; I Gastinger; F Meyer; A Ilsemann; H Lippert; C Bruns
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.